At a glance
ClinicalIndex Comparison RecordN/ACompleted· 88 enrolled
Drug / intervention
Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-randomized Study of the Avinger Wildcat Used to Cross Femoropopliteal CTOs
In Brief
A clinical study evaluating Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTer for Peripheral Arterial Disease. Completed, enrolled 88 participants across 15 sites.
Detailed Summary
This is a prospective, multi-center, non-randomized study of the Wildcat Catheter to cross a single femoropopliteal chronic total occlusion (CTO). Safety and efficacy will be evaluated during the index procedure through 30-day follow-up.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedAug 2010
Primary CompletionApr 2011
Study CompletionJun 2011
TodayJul 2026
First PostedAug 4, 2010
Enrollment StartAug 1, 2010
Primary CompletionApr 1, 2011
Study CompletionJun 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.9 years ago
Interventions
Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTerdevice
A Non-Randomized Study of the Avinger Wildcat™ used to Cross Chronic Total Occlusions in the Superficial Femoral and Popliteal Arteries